Effect of Cannabis and Cigarette Smoking on Oral Mucosa

Study Overview
=================
Brief Summary
-----------------
The aim of this study is to detect P53 expression in clinically normal oral mucosa of cigarette smokers, simultaneous cigarette and cannabis smokers and non-smokers as a surrogate marker for field cancerization.

Detailed Description
-----------------
Roles and Responsibilities: Ali Abd El Wahed Abd El Fatah Kotb (A.K.) operator, data enterer, Assistant lecturer, Oral and Maxillofacial Pathology, Faculty of Oral and Dental Medicine, Cairo university, Egypt. Professor Dr. Heba Dahmoush (H.D.) main supervisor, data monitoring,auditing professor, Oral and Maxillofacial Pathology, Faculty of Oral and Dental Medicine, Cairo university, Egypt. Eman Desoky (E.D.) sample size calculation, statistician,Faculty of Oral and Dental Medicine, Cairo University, Egypt. Evidence Based Dentistry Committee (CEBD)help in reporting study protocol following SPIRIT guidelines,Faculty of Oral and Dental Medicine, Cairo University, Egypt. Research Ethics Comittee (CREC)protocol reviewer in order to protect the right, safety, dignity and well-being of the participants, Faculty of Oral and Dental Medicine, Cairo University, Egypt. 1- Intervention: A.K. will collect specimens from cigarette smokers and simultaneous cigarette and cannabis smokers. then the expression of p53 as a marker for field cancerization will be investigated in formaline fixed paraffine embedded specimens of mucosal biopsies obtained from the oral mucosa of both groups. 2-comparator: mucosal biopsies from non smokers will be investigated as a copmaratitive to smokers group.

Official Title
-----------------
Detection of Field Cancerization in the Clinically Normal Oral Mucosa of Cannabis and Cigarette Smokers (Ex-vivo Study)

Conditions
-----------------
Field Cancerization for Cannabis Smokers

Intervention / Treatment
-----------------
* Other: Cigarette smokers
* Other: Simultaneous cigarette and cannabis smokers


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: frequent smokers (at least 10 cigarettes a day) for a period not less than 5 years. Simultaneous smokers to be included in the study must be frequent cigarette smokers (at least 10 cigarettes a day) for a period not less than 5 years plus frequent cannabis smoker (at least 3 times per week) for a period not less than 5 years. Exclusion Criteria: Exposure to other carcinogens. un-clear smoking history. medically compromised patients
Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| non smokers<br> | |
| cigarette smokers<br>Cigarette smokers to be included in the study must be frequent smokers (at least 10 cigarettes a day) for a period not less than 5 years. | Other: Cigarette smokers<br>* frequent cigarette smoking for not less than 5 years<br>|
| simultaneous cigarette and cannabis smokers<br>frequent cigarette smokers (at least 10 cigarettes a day) and frequent cannabis smoker (at least 3 times/week) for not less than 5 years. | Other: Simultaneous cigarette and cannabis smokers<br>* frequent cigarette and cannabis smoking for not less than 5 years<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| P53 expression as a surrogate marker for field cancerization | The areas containing the most uniformly stained tissues will be chosen for evaluation in area-area/area-percent measurments | not less than 5 years |